XPH vs. GLD
XPH (SPDR S&P Pharmaceuticals ETF) and GLD (SPDR Gold Shares) are both exchange-traded funds - XPH is a Health & Biotech Equities fund tracking the S&P Pharmaceuticals Select Industry Index, while GLD is a Gold fund tracking the LBMA Gold Price PM. Both are passively managed. Over the past 10 years, XPH returned 3.44%/yr vs 13.12%/yr for GLD. At a 0.03 correlation, their price movements are largely independent. XPH charges 0.35%/yr vs 0.40%/yr for GLD.
Performance
XPH vs. GLD - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, XPH achieves a 0.66% return, which is significantly lower than GLD's 2.92% return. Over the past 10 years, XPH has underperformed GLD with an annualized return of 3.44%, while GLD has yielded a comparatively higher 13.12% annualized return.
XPH
- 1D
- 1.10%
- 1M
- -4.74%
- YTD
- 0.66%
- 6M
- 4.44%
- 1Y
- 37.98%
- 3Y*
- 13.07%
- 5Y*
- 3.50%
- 10Y*
- 3.44%
GLD
- 1D
- -0.99%
- 1M
- -1.65%
- YTD
- 2.92%
- 6M
- 5.43%
- 1Y
- 32.04%
- 3Y*
- 31.09%
- 5Y*
- 18.15%
- 10Y*
- 13.12%
XPH vs. GLD - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
XPH SPDR S&P Pharmaceuticals ETF | 0.66% | 31.60% | 4.94% | 2.97% | -9.83% | -10.54% | 14.68% | 25.61% | -15.32% | 12.05% |
GLD SPDR Gold Shares | 2.92% | 63.68% | 26.66% | 12.69% | -0.77% | -4.15% | 24.81% | 17.86% | -1.94% | 12.81% |
Correlation
The correlation between XPH and GLD is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.15 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.13 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.11 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.05 |
Correlation (All Time) Calculated using the full available price history since Jun 23, 2006 | 0.03 |
The correlation between XPH and GLD shifts across timeframes, from 0.03 (all time) to 0.15 (1 year), reflecting how their relationship changes across market environments.
XPH vs. GLD - Sectors Allocation Comparison
Sectors
XPH
GLD
Healthcare
-
Basic Materials
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
XPH
GLD
-
Basic Materials
XPH
-
GLD
Communication Services
XPH
-
GLD
-
Consumer Cyclical
XPH
-
GLD
-
Consumer Defensive
XPH
-
GLD
-
Energy
XPH
-
GLD
-
Financial Services
XPH
-
GLD
-
Industrials
XPH
-
GLD
-
Real Estate
XPH
-
GLD
-
Technology
XPH
-
GLD
-
Utilities
XPH
-
GLD
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XPH vs. GLD — Risk / Return Rank
XPH
GLD
XPH vs. GLD - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for SPDR S&P Pharmaceuticals ETF (XPH) and SPDR Gold Shares (GLD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| XPH | GLD | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.56 | ||
| Sortino ratioReturn per unit of downside risk | +0.91 | ||
| Omega ratioGain probability vs. loss probability | 1.30 | 1.24 | +0.05 |
| Calmar ratioReturn relative to maximum drawdown | 3.19 | 1.68 | +1.51 |
| Martin ratioReturn relative to average drawdown | 11.37 | 4.15 | +7.22 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| XPH | GLD | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.77 | 1.21 | +0.56 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.17 | 1.01 | -0.85 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.16 | 0.83 | -0.67 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.38 | 0.60 | -0.22 |
Drawdowns
XPH vs. GLD - Drawdown Comparison
The maximum XPH drawdown since its inception was -48.03%, which is greater than GLD's maximum drawdown of -45.56%. Use the drawdown chart below to compare losses from any high point for XPH and GLD.
Loading charts...
Drawdown Indicators
| XPH | GLD | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -48.03% | -45.56% | -2.47% |
Max Drawdown (1Y)Largest decline over 1 year | -11.97% | -19.21% | +7.24% |
Max Drawdown (3Y)Largest decline over 3 years | -23.57% | -19.21% | -4.36% |
Max Drawdown (5Y)Largest decline over 5 years | -31.63% | -21.03% | -10.60% |
Max Drawdown (10Y)Largest decline over 10 years | -35.97% | -22.00% | -13.97% |
Current DrawdownCurrent decline from peak | -7.22% | -17.75% | +10.53% |
Average DrawdownAverage peak-to-trough decline | -17.25% | -16.16% | -1.09% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.35% | 7.73% | -4.38% |
Volatility
XPH vs. GLD - Volatility Comparison
SPDR S&P Pharmaceuticals ETF (XPH) has a higher volatility of 7.03% compared to SPDR Gold Shares (GLD) at 5.51%. This indicates that XPH's price experiences larger fluctuations and is considered to be riskier than GLD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| XPH | GLD | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.03% | 5.51% | +1.52% |
Volatility (6M)Calculated over the trailing 6-month period | 16.77% | 23.16% | -6.39% |
Volatility (1Y)Calculated over the trailing 1-year period | 21.52% | 26.61% | -5.09% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 20.84% | 18.00% | +2.84% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.10% | 15.95% | +6.15% |
XPH vs. GLD - Expense Ratio Comparison
XPH has a 0.35% expense ratio, which is lower than GLD's 0.40% expense ratio.
Dividends
XPH vs. GLD - Dividend Comparison
XPH's dividend yield for the trailing twelve months is around 0.66%, while GLD has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GLD SPDR Gold Shares | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
XPH SPDR S&P Pharmaceuticals ETF | 0.66% | 0.83% | 1.58% | 1.28% | 1.64% | 0.95% | 0.47% | 0.64% | 0.65% | 0.67% | 0.63% | 7.15% |
Frequently Asked Questions
XPH and GLD have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
XPH has higher volatility (7.03%) compared to GLD (5.51%). In terms of maximum drawdown, XPH dropped -48.03% vs GLD's -45.56%.
On 10-year performance, GLD leads with 13.12% vs 3.44% for XPH. On fees, XPH is cheaper at 0.35% per year. On volatility, GLD has been the lower-risk option at 5.51%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, GLD has performed better with a 13.12% return vs 3.44%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
XPH is cheaper with a 0.35% expense ratio, compared with 0.40% for GLD.
XPH has the higher dividend yield at 0.66%, compared with 0.00% for GLD.
XPH is categorized as Health & Biotech Equities, while GLD is Gold. XPH tracks S&P Pharmaceuticals Select Industry Index, while GLD tracks LBMA Gold Price PM. Their fees differ too: 0.35% for XPH and 0.40% for GLD.
XPH currently has the higher Sharpe Ratio (1.77 vs 1.21), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for XPH and GLD
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer